256
Participants
Start Date
February 15, 2021
Primary Completion Date
August 4, 2021
Study Completion Date
August 4, 2021
Atazanavir
600 mg (2 capsules) twice daily on the first day and 300 mg (1 capsule) twice daily for the subsequent 9 days.
Daclatasvir 60 mg
initial dose of 120mg (2 capsules), followed by 60mg (1 capsule) once daily for 9 days.
Sofusbuvir + Daclastavir 60 mg
400 mg twice daily (2 capsules) on the first day and 400 mg (1 capsules) once daily for the subsequent 9 days (sofusbuvir) + initial dose of 120mg (2 capsules), followed by 60mg (1 capsule) once a day for 9 days (daclastavir)
Placebo Atazanavir
2 capsules twice daily on the first day and 1 capsule twice daily for the subsequent 9 days.
Placebo Daclatasvir 60 mg
2 capsules twice daily on the first day and 1 capsule twice daily for the subsequent 9 days.
Placebo Sofusbuvir + Daclatasvir 60 mg
2 capsules twice daily on the first day and 1 capsule twice daily for the subsequent 9 days.
Hospital do Coracao, São Paulo
Hospital do Coracao
OTHER